Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 4,527 |
|
|||||
| News | - | ||||||
| Day High | 1.10 | Low High |
|||||
| Day Low | 1.00 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Arch Therapeutics Inc (QB) | ARTH | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.05 | 5.26% | 1.00 | 15:30:10 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.00 | 1.00 | 1.10 | 1.00 | 0.95 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 14 | 4,527 | US$ 1.0111 | US$ 4,577 | - | 0.39 - 18.00 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:32:20 | 3,700 | US$ 1.00 | USD |
Arch Therapeutics Inc (QB) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.74M | 1.29M | 1.02M | 76k | -6.98M | -1.47 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Arch Therapeutics (QB) News
Real-Time news about Arch Therapeutics Inc (QB) (OTCMarkets): 0 recent articles
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARTH Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.11 | 1.13 | 0.95 | 1.04 | 3,533 | -0.11 | -9.91% |
| 1 Month | 1.05 | 1.567 | 0.95 | 1.15 | 2,490 | -0.05 | -4.76% |
| 3 Months | 1.985 | 2.14 | 0.74 | 1.32 | 2,965 | -0.985 | -49.62% |
| 6 Months | 10.63 | 10.63 | 0.74 | 4.94 | 9,628 | -9.63 | -90.59% |
| 1 Year | 3.15 | 18.00 | 0.39 | 4.95 | 10,057 | -2.15 | -68.25% |
| 3 Years | 22.00 | 28.00 | 0.39 | 13.25 | 194,496 | -21.00 | -95.45% |
| 5 Years | 63.24 | 75.00 | 0.39 | 26.57 | 254,694 | -62.24 | -98.42% |
Arch Therapeutics (QB) Description
| Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's products authorized for commercial marketing are AC5 Advanced Wound System and AC5 Topical Hemostat. Arch's development stage product candidates include AC5-GTM and AC5 Surgical Hemostat, among others. |
